Strides Arcolab to buy Shasun Pharma in all-stock deal
Shasun shareholders will get five shares of Strides for every 16 held in Shasun
)
Strides-Arcolab
Generic drugmaker Strides Arcolab Ltd said on Monday it had agreed to merge with smaller peer Shasun Pharmaceuticals Ltd in an all-stock deal.
Shasun shareholders will get five shares of Strides for every 16 held in Shasun, the companies said in a joint statement.
Shasun shareholders will own 26% of the combined entity, the statement said.
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Sep 29 2014 | 3:35 PM IST